Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
City of Hope Medical Center
Thomas Jefferson University
Thomas Jefferson University
Stanford University
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
University of Alabama at Birmingham
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Massachusetts General Hospital
National Heart, Lung, and Blood Institute (NHLBI)
University of Illinois at Chicago
Wake Forest University Health Sciences
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
Mayo Clinic
University of Chicago
University of Rochester
National Institutes of Health Clinical Center (CC)
Indiana University
Indiana University
Duke University
The Emmes Company, LLC
Amgen
Mayo Clinic